{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:11:44Z","timestamp":1794028304262,"version":"4.8.0"},"reference-count":97,"publisher":"American Society of Hematology","issue":"7","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4,14]]},"abstract":"<jats:sec>\n                    <jats:title>Abstract<\/jats:title>\n                    <jats:p>Von Willebrand factor (VWF) is a key coagulation protein, tethering platelets to the sites of injury through binding sites for platelet glycoprotein Ib\u03b1 and exposed subendothelial collagen. VWF synthesis occurs in endothelial cells and megakaryocytes, a complex process involving the VWF propeptide, dimerization and multimerization, and glycosylation. Von Willebrand disease results from defects or dysfunction in VWF and includes both quantitative and qualitative issues with the VWF protein. VWF is cleaved by ADAMTS13 and ultimately cleared from circulation. Although it is clear that VWF plays an important role in clot formation, it may also be important in a number of other areas including angiogenesis. Our knowledge of VWF has come a long way in the 100 years since the first publication by Erik von Willebrand in 1926 thanks to a large number of researchers in the VWF biology field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1182\/bloodadvances.2025016484","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T20:10:21Z","timestamp":1769717421000},"page":"2417-2424","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":1,"title":["Biology of von Willebrand disease"],"prefix":"10.1182","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8998-6838","authenticated-orcid":false,"given":"Veronica H.","family":"Flood","sequence":"first","affiliation":[{"name":"1Division of Pediatric Hematology\/Oncology\/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI"},{"name":"2Children\u2019s Research Institute, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI"},{"name":"3Versiti Blood Research Institute, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5545-8014","authenticated-orcid":false,"given":"Sandra L.","family":"Haberichter","sequence":"additional","affiliation":[{"name":"1Division of Pediatric Hematology\/Oncology\/Blood and Marrow Transplant, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI"},{"name":"2Children\u2019s Research Institute, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI"},{"name":"3Versiti Blood Research Institute, Milwaukee, WI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"3","key":"2026041408012456500_bib1","first-page":"223-222","article-title":"Hereditary pseudohaemophilia","volume":"5","author":"Von Willebrand","year":"1999","journal-title":"Haemophilia"},{"key":"2026041408012456500_bib2","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/0002-9343(63)90057-3","article-title":"von Willebrand\u2019s disease","volume":"34","author":"Blomback","year":"1963","journal-title":"Am J Med"},{"issue":"3","key":"2026041408012456500_bib3","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.0954-6820.1957.tb00123.x","article-title":"Von Willebrand\u2019s disease and its correction with human plasma fraction 1-0","volume":"159","author":"Nilsson","year":"1957","journal-title":"Acta Med Scand"},{"issue":"1","key":"2026041408012456500_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2516.2011.02718.x","article-title":"Memories of my research into von Willebrand\u2019s disease","volume":"18","author":"Blomb\u00e4ck","year":"2012","journal-title":"Haemophilia"},{"issue":"1","key":"2026041408012456500_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI106480","article-title":"Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand\u2019s dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor","volume":"50","author":"Zimmerman","year":"1971","journal-title":"J Clin Invest"},{"issue":"5","key":"2026041408012456500_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/blood.V41.5.687.687","article-title":"Ristocetin: a means of differentiating von Willebrand\u2019s disease into two groups","volume":"41","author":"Howard","year":"1973","journal-title":"Blood"},{"issue":"3","key":"2026041408012456500_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1182\/blood.V45.3.403.403","article-title":"Abnormalities of factor VIII and platelet aggregation--use of ristocetin in diagnosing the von Willebrand syndrome","volume":"45","author":"Weiss","year":"1975","journal-title":"Blood"},{"issue":"4","key":"2026041408012456500_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1056\/NEJM195807242590402","article-title":"Hematologic complications arising during ristocetin therapy; relation between dose and toxicity","volume":"259","author":"Gangarosa","year":"1958","journal-title":"N Engl J Med"},{"issue":"1","key":"2026041408012456500_bib9","first-page":"152","article-title":"Determination of the von Willebrand\u2019s disease antigen (factor VIII-related antigen) in plasma by quantitative immunoelectrophoresis","volume":"86","author":"Zimmerman","year":"1975","journal-title":"J Lab Clin Med"},{"issue":"6","key":"2026041408012456500_bib10","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1172\/JCI109070","article-title":"von Willebrand\u2019s disease antigen II. A new plasma and platelet antigen deficient in severe von Willebrand\u2019s disease","volume":"61","author":"Montgomery","year":"1978","journal-title":"J Clin Invest"},{"issue":"5992","key":"2026041408012456500_bib11","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/312326a0","article-title":"Characterization of the human factor VIII gene","volume":"312","author":"Gitschier","year":"1984","journal-title":"Nature"},{"issue":"5992","key":"2026041408012456500_bib12","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/312342a0","article-title":"Molecular cloning of a cDNA encoding human antihaemophilic factor","volume":"312","author":"Toole","year":"1984","journal-title":"Nature"},{"issue":"4706","key":"2026041408012456500_bib13","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (vWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"issue":"1","key":"2026041408012456500_bib14","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","article-title":"Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method","volume":"41","author":"Lynch","year":"1985","journal-title":"Cell"},{"issue":"33","key":"2026041408012456500_bib15","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"J Biol Chem"},{"issue":"1","key":"2026041408012456500_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1365-2141.1991.tb04385.x","article-title":"Characterization of the pseudogenic and genic homologous regions of von Willebrand factor","volume":"78","author":"Marchetti","year":"1991","journal-title":"Br J Haematol"},{"issue":"5","key":"2026041408012456500_bib17","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1073\/pnas.71.5.1906","article-title":"Synthesis of von Willebrand factor by cultured human endothelial cells","volume":"71","author":"Jaffe","year":"1974","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"2026041408012456500_bib18","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1083\/jcb.99.6.2123","article-title":"Biosynthesis of von Willebrand protein by human endothelial cells: processing steps and their intracellular localization","volume":"99","author":"Wagner","year":"1984","journal-title":"J Cell Biol"},{"issue":"2","key":"2026041408012456500_bib19","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1042\/BJ20120810","article-title":"Mapping the N-glycome of human von Willebrand factor","volume":"447","author":"Canis","year":"2012","journal-title":"Biochem J"},{"issue":"1","key":"2026041408012456500_bib20","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1182\/blood-2012-02-410050","article-title":"O-linked glycosylation of von Willebrand factor modulates the interaction with platelet receptor glycoprotein Ib under static and shear stress conditions","volume":"120","author":"Nowak","year":"2012","journal-title":"Blood"},{"issue":"9","key":"2026041408012456500_bib21","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood.V79.9.2349.2349","article-title":"Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes","volume":"79","author":"Rehemtulla","year":"1992","journal-title":"Blood"},{"issue":"4","key":"2026041408012456500_bib22","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1083\/jcb.102.4.1320","article-title":"Initial glycosylation and acidic pH in the Golgi apparatus are required for multimerization of von Willebrand factor","volume":"102","author":"Wagner","year":"1986","journal-title":"J Cell Biol"},{"issue":"1","key":"2026041408012456500_bib23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1083\/jcb.95.1.355","article-title":"Immunolocalization of von Willebrand protein in Weibel-Palade bodies of human endothelial cells","volume":"95","author":"Wagner","year":"1982","journal-title":"J Cell Biol"},{"key":"2026041408012456500_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.cb.06.110190.001245","article-title":"Cell biology of von Willebrand factor","volume":"6","author":"Wagner","year":"1990","journal-title":"Annu Rev Cell Biol"},{"issue":"2","key":"2026041408012456500_bib25","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/0092-8674(88)90511-9","article-title":"The propeptide of von Willebrand factor independently mediates the assembly of von Willebrand multimers","volume":"52","author":"Wise","year":"1988","journal-title":"Cell"},{"issue":"2","key":"2026041408012456500_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/0092-8674(91)90648-I","article-title":"Induction of specific storage organelles by von Willebrand factor propolypeptide","volume":"64","author":"Wagner","year":"1991","journal-title":"Cell"},{"issue":"1","key":"2026041408012456500_bib27","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1172\/JCI9516","article-title":"Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP","volume":"106","author":"Kaufmann","year":"2000","journal-title":"J Clin Invest"},{"issue":"2","key":"2026041408012456500_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence-based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"issue":"19","key":"2026041408012456500_bib29","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1182\/blood-2015-03-629832","article-title":"VWF propeptide in defining VWD subtypes","volume":"125","author":"Haberichter","year":"2015","journal-title":"Blood"},{"issue":"6","key":"2026041408012456500_bib30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S0025-6196(12)60524-2","article-title":"Platelet von Willebrand factor","volume":"66","author":"Gralnick","year":"1991","journal-title":"Mayo Clin Proc"},{"issue":"17","key":"2026041408012456500_bib31","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1182\/blood.2024027935","article-title":"A novel cause of type 1 von Willebrand disease: impaired exocytosis of Weibel-Palade bodies due to biallelic MADD variants","volume":"146","author":"Hordijk","year":"2025","journal-title":"Blood"},{"issue":"12","key":"2026041408012456500_bib32","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1111\/jth.14304","article-title":"Genetic regulation of plasma von Willebrand factor levels in health and disease","volume":"16","author":"Swystun","year":"2018","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026041408012456500_bib33","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1182\/blood-2012-01-405134","article-title":"Sequence and structure relationships within von Willebrand factor","volume":"120","author":"Zhou","year":"2012","journal-title":"Blood"},{"issue":"17","key":"2026041408012456500_bib34","doi-asserted-by":"crossref","first-page":"7880","DOI":"10.1073\/pnas.89.17.7880","article-title":"A monomeric von Willebrand factor fragment, Leu-504--Lys-728, inhibits von Willebrand factor interaction with glycoprotein Ib-IX [corrected]","volume":"89","author":"Gralnick","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026041408012456500_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI110946","article-title":"Platelets have more than one binding site for von Willebrand factor","volume":"72","author":"Ruggeri","year":"1983","journal-title":"J Clin Invest"},{"issue":"28","key":"2026041408012456500_bib36","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"issue":"33","key":"2026041408012456500_bib37","first-page":"19668-10827","article-title":"Interaction of the von Willebrand factor (vWF) with collagen. Localization of the primary collagen-binding site by analysis of recombinant vWF a domain polypeptides","volume":"270","author":"Cruz","year":"1995","journal-title":"J Biol Chem"},{"issue":"5","key":"2026041408012456500_bib38","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1182\/blood.V83.5.1244.1244","article-title":"Platelet adhesion to collagen types I through VIII under conditions of stasis and flow is mediated by GPIa\/IIa (alpha 2 beta 1-integrin)","volume":"83","author":"Saelman","year":"1994","journal-title":"Blood"},{"issue":"Pt 1","key":"2026041408012456500_bib39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/bj3240185","article-title":"von Willebrand factor binds to native collagen VI primarily via its A1 domain","volume":"324","author":"Hoylaerts","year":"1997","journal-title":"Biochem J"},{"issue":"3","key":"2026041408012456500_bib40","first-page":"848","article-title":"Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen","volume":"86","author":"Ribba","year":"2001","journal-title":"Thromb Haemost"},{"issue":"7","key":"2026041408012456500_bib41","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/j.1538-7836.2012.04747.x","article-title":"Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease","volume":"10","author":"Flood","year":"2012","journal-title":"J Thromb Haemost"},{"issue":"2","key":"2026041408012456500_bib42","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI108788","article-title":"Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand\u2019s disease","volume":"60","author":"Weiss","year":"1977","journal-title":"J Clin Invest"},{"issue":"5","key":"2026041408012456500_bib43","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/pbc.20658","article-title":"Regulated release of VWF and FVIII and the biologic implications","volume":"46","author":"Haberichter","year":"2006","journal-title":"Pediatr Blood Cancer"},{"issue":"24","key":"2026041408012456500_bib44","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1182\/blood-2014-02-555151","article-title":"A conditional knockout mouse model reveals endothelial cells as the principal and possibly exclusive source of plasma factor VIII","volume":"123","author":"Fahs","year":"2014","journal-title":"Blood"},{"issue":"24","key":"2026041408012456500_bib45","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1182\/blood-2014-02-554501","article-title":"Murine coagulation factor VIII is synthesized in endothelial cells","volume":"123","author":"Everett","year":"2014","journal-title":"Blood"},{"issue":"6","key":"2026041408012456500_bib46","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1365-2516.2009.02062.x","article-title":"Undetected factor VIII in a patient with type 3 von Willebrands disease mistaken as severe haemophilia A","volume":"15","author":"Mullah-Ali","year":"2009","journal-title":"Haemophilia"},{"key":"2026041408012456500_bib47","first-page":"196","article-title":"Gastrointestinal bleeding in aortic stenosis","volume":"259","author":"Heyde","year":"1956","journal-title":"N.Engl.J.Med"},{"issue":"Suppl 2","key":"2026041408012456500_bib48","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1016\/S0049-3848(16)30366-8","article-title":"Endothelial dysfunction in von Willebrand disease: angiogenesis and angiodysplasia","volume":"141","author":"Randi","year":"2016","journal-title":"Thromb Res"},{"issue":"3","key":"2026041408012456500_bib49","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","article-title":"Endothelial von Willebrand factor regulates angiogenesis","volume":"117","author":"Starke","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2026041408012456500_bib50","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/jth.13551","article-title":"Von Willebrand factor and angiogenesis: basic and applied issues","volume":"15","author":"Randi","year":"2017","journal-title":"J Thromb Haemost"},{"key":"2026041408012456500_bib51","doi-asserted-by":"crossref","first-page":"102204","DOI":"10.1016\/j.rpth.2023.102204","article-title":"Angiopoietin-2 binds to multiple interactive sites within von Willebrand factor","volume":"7","author":"Texier","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"10","key":"2026041408012456500_bib52","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1182\/blood.V87.10.4223.bloodjournal87104223","article-title":"Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis","volume":"87","author":"Furlan","year":"1996","journal-title":"Blood"},{"issue":"12","key":"2026041408012456500_bib53","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1182\/blood-2011-02-306597","article-title":"Unraveling the scissile bond: how ADAMTS13 recognizes and cleaves von Willebrand factor","volume":"118","author":"Crawley","year":"2011","journal-title":"Blood"},{"issue":"suppl 1","key":"2026041408012456500_bib54","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jth.12221","article-title":"Structure-function and regulation of ADAMTS-13 protease","volume":"11","author":"Zheng","year":"2013","journal-title":"J Thromb Haemost"},{"issue":"29","key":"2026041408012456500_bib55","doi-asserted-by":"crossref","first-page":"10578","DOI":"10.1073\/pnas.0402041101","article-title":"Binding of platelet glycoprotein Ibalpha to von Willebrand factor domain A1 stimulates the cleavage of the adjacent domain A2 by ADAMTS13","volume":"101","author":"Nishio","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"2026041408012456500_bib56","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","article-title":"Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura","volume":"307","author":"Moake","year":"1982","journal-title":"N Engl J Med"},{"issue":"12","key":"2026041408012456500_bib57","doi-asserted-by":"crossref","first-page":"5357","DOI":"10.1016\/S0021-9258(18)50603-7","article-title":"Human platelets possess an inducible and saturable receptor specific for fibrinogen","volume":"254","author":"Marguerie","year":"1979","journal-title":"J Biol Chem"},{"issue":"2","key":"2026041408012456500_bib58","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1172\/JCI111228","article-title":"Interaction of von Willebrand factor with human platelets in the plasma milieu","volume":"73","author":"Schullek","year":"1984","journal-title":"J Clin Invest"},{"issue":"21","key":"2026041408012456500_bib59","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood.V116.21.236.236","article-title":"Regular replacement therapy as prophylaxis in severe forms of von Willebrand disease: initial results from the von Willebrand Disease Prophylaxis Network (VWD PN) Study Group","volume":"116","author":"Berntorp","year":"2010","journal-title":"Blood"},{"issue":"3","key":"2026041408012456500_bib60","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev"},{"issue":"1","key":"2026041408012456500_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41572-024-00536-8","article-title":"von Willebrand disease","volume":"10","author":"Seidizadeh","year":"2024","journal-title":"Nat Rev Dis Primers"},{"issue":"13","key":"2026041408012456500_bib62","doi-asserted-by":"crossref","first-page":"4031","DOI":"10.1182\/bloodadvances.2022007216","article-title":"Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2","volume":"6","author":"Seidizadeh","year":"2022","journal-title":"Blood Adv"},{"issue":"10","key":"2026041408012456500_bib63","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1182\/blood.V87.10.4235.bloodjournal87104235","article-title":"Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion","volume":"87","author":"Tsai","year":"1996","journal-title":"Blood"},{"issue":"7","key":"2026041408012456500_bib64","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"J Biol Chem"},{"issue":"19","key":"2026041408012456500_bib65","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1182\/blood-2011-06-360875","article-title":"Intersection of mechanisms of type 2A VWD through defects in VWF multimerization, secretion, ADAMTS-13 susceptibility, and regulated storage","volume":"119","author":"Jacobi","year":"2012","journal-title":"Blood"},{"issue":"4","key":"2026041408012456500_bib66","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI115123","article-title":"The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain","volume":"87","author":"Cooney","year":"1991","journal-title":"J Clin Invest"},{"issue":"8","key":"2026041408012456500_bib67","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1182\/blood.V79.8.2048.2048","article-title":"Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets","volume":"79","author":"Kroner","year":"1992","journal-title":"Blood"},{"issue":"3","key":"2026041408012456500_bib68","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood"},{"issue":"20","key":"2026041408012456500_bib69","doi-asserted-by":"crossref","first-page":"9846","DOI":"10.1073\/pnas.89.20.9846","article-title":"von Willebrand disease type B: a missense mutation selectively abolishes ristocetin-induced von Willebrand factor binding to platelet glycoprotein Ib","volume":"89","author":"Rabinowitz","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2026041408012456500_bib70","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2026041408012456500_bib71","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2010-08-299016","article-title":"Gain-of-function GPIb ELISA assay for VWF activity in the Zimmerman program for the molecular and clinical biology of VWD","volume":"117","author":"Flood","year":"2011","journal-title":"Blood"},{"issue":"1","key":"2026041408012456500_bib72","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv"},{"issue":"1","key":"2026041408012456500_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V75.1.20.20","article-title":"A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF\/FVIII interaction","volume":"75","author":"Mazurier","year":"1990","journal-title":"Blood"},{"issue":"4","key":"2026041408012456500_bib74","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.15247","article-title":"Von Willebrand disease type 2N: an update","volume":"19","author":"Seidizadeh","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"15","key":"2026041408012456500_bib75","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.1016\/S0021-9258(19)63384-3","article-title":"Relationship of sialic acid to function and in vivo survival of human factor VIII\/von Willebrand factor protein","volume":"252","author":"Sodetz","year":"1977","journal-title":"J Biol Chem"},{"issue":"6","key":"2026041408012456500_bib76","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1182\/blood.V69.6.1691.1691","article-title":"The effect of ABO blood group on the diagnosis of von Willebrand disease","volume":"69","author":"Gill","year":"1987","journal-title":"Blood"},{"issue":"1","key":"2026041408012456500_bib77","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V99.1.180","article-title":"Reduced von Willebrand factor survival in type Vicenza von Willebrand disease","volume":"99","author":"Casonato","year":"2002","journal-title":"Blood"},{"issue":"10","key":"2026041408012456500_bib78","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood-2006-04-015065","article-title":"Assay of the von Willebrand factor (VWF) propeptide to identify patients with type 1 von Willebrand disease with decreased VWF survival","volume":"108","author":"Haberichter","year":"2006","journal-title":"Blood"},{"issue":"12","key":"2026041408012456500_bib79","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood-2012-09-455089","article-title":"VWF propeptide and ratios between VWF, VWF propeptide, and FVIII in the characterization of type 1 von Willebrand disease","volume":"121","author":"Eikenboom","year":"2013","journal-title":"Blood"},{"issue":"5","key":"2026041408012456500_bib80","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.jtha.2023.01.012","article-title":"Genetic determinants of enhanced von Willebrand factor clearance from plasma","volume":"21","author":"Seidizadeh","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"9","key":"2026041408012456500_bib81","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1182\/blood-2011-08-373605","article-title":"Macrophage LRP1 contributes to the clearance of von Willebrand factor","volume":"119","author":"Rastegarlari","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2026041408012456500_bib82","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/bjh.15565","article-title":"von Willebrand factor clearance - biological mechanisms and clinical significance","volume":"183","author":"O\u2019Sullivan","year":"2018","journal-title":"Br J Haematol"},{"issue":"12","key":"2026041408012456500_bib83","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/CIRCULATIONAHA.109.869156","article-title":"Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor: the CHARGE (Cohorts for Heart and Aging Research in Genome Epidemiology) Consortium","volume":"121","author":"Smith","year":"2010","journal-title":"Circulation"},{"issue":"8","key":"2026041408012456500_bib84","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.jtha.2023.04.014","article-title":"The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF-FVIII clearance in thrombosis and hemostasis","volume":"21","author":"Swystun","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"26","key":"2026041408012456500_bib85","doi-asserted-by":"crossref","first-page":"5228","DOI":"10.1182\/blood-2012-10-457507","article-title":"The C-type lectin receptor CLEC4M binds, internalizes, and clears von Willebrand factor and contributes to the variation in plasma von Willebrand factor levels","volume":"121","author":"Rydz","year":"2013","journal-title":"Blood"},{"issue":"9","key":"2026041408012456500_bib86","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1172\/JCI96400","article-title":"The endothelial cell receptor stabilin-2 regulates VWF-FVIII complex half-life and immunogenicity","volume":"128","author":"Swystun","year":"2018","journal-title":"J Clin Invest"},{"issue":"8","key":"2026041408012456500_bib87","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/jth.14521","article-title":"The scavenger receptor SCARA5 is an endocytic receptor for von Willebrand factor expressed by littoral cells in the human spleen","volume":"17","author":"Swystun","year":"2019","journal-title":"J Thromb Haemost"},{"issue":"4","key":"2026041408012456500_bib88","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa2209226","article-title":"Efanesoctocog alfa prophylaxis for patients with severe hemophilia A","volume":"388","author":"von Drygalski","year":"2023","journal-title":"N Engl J Med"},{"issue":"15","key":"2026041408012456500_bib89","doi-asserted-by":"crossref","first-page":"10042","DOI":"10.1073\/pnas.142005099","article-title":"Sialyltransferase ST3Gal-IV operates as a dominant modifier of hemostasis by concealing asialoglycoprotein receptor ligands","volume":"99","author":"Ellies","year":"2002","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"2026041408012456500_bib90","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1161\/ATVBAHA.117.309918","article-title":"Endothelial cell-derived von Willebrand factor, but not platelet-derived, promotes atherosclerosis in apolipoprotein E-deficient mice","volume":"38","author":"Doddapattar","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"5","key":"2026041408012456500_bib91","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/jth.13294","article-title":"Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms","volume":"14","author":"Alb\u00e1nez","year":"2016","journal-title":"J Thromb Haemost"},{"issue":"11","key":"2026041408012456500_bib92","doi-asserted-by":"crossref","first-page":"e908","DOI":"10.1016\/S2352-3026(25)00262-5","article-title":"Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implications","volume":"12","author":"Seidizadeh","year":"2025","journal-title":"Lancet Haematol"},{"issue":"12","key":"2026041408012456500_bib93","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1182\/blood.2023021915","article-title":"Novel functions for von Willebrand factor","volume":"144","author":"Atiq","year":"2024","journal-title":"Blood"},{"issue":"24","key":"2026041408012456500_bib94","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.2019000510","article-title":"The heparin binding domain of von Willebrand factor binds to growth factors and promotes angiogenesis in wound healing","volume":"133","author":"Ishihara","year":"2019","journal-title":"Blood"},{"issue":"2","key":"2026041408012456500_bib95","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0037-1607352","article-title":"Emerging roles for von Willebrand factor in cancer cell biology","volume":"44","author":"O\u2019Sullivan","year":"2018","journal-title":"Semin Thromb Hemost"},{"issue":"2","key":"2026041408012456500_bib96","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood"},{"issue":"1","key":"2026041408012456500_bib97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41525-023-00375-8","article-title":"Population-based prevalence and mutational landscape of von Willebrand disease using large-scale genetic databases","volume":"8","author":"Seidizadeh","year":"2023","journal-title":"NPJ Genom Med"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2417\/2512000\/blooda_adv-2025-016484-c-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/10\/7\/2417\/2512000\/blooda_adv-2025-016484-c-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T12:01:37Z","timestamp":1776168097000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/10\/7\/2417\/566326\/Biology-of-von-Willebrand-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":97,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,4,14]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2025016484","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4,14]]},"published":{"date-parts":[[2026,4,1]]}}}